Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (Danube): a randomised, open-label, multicentre, phase 3 trial
Your card will only be charged after your prescription has been approved by a licensed physician
Semaglutide for managing overweight and obesity (TA875) NICE
Get less sick
Here's why that combination is interesting: rapamycin inhibits mTOR, the cellular growth pathway that, when chronically overactivated, drives cellular senescence in follicle stem cell niches
US$ 20.56
US$ 28.53
US$ 24.06
